OTCPK:ATHJF (Australia)  
Antisense Therapeutics Ltd logo

Antisense Therapeutics Ltd

$ 0.06 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
2.66
Market Cap:
$ 36.15M
Enterprise V:
$ 24.71M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
36.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
24.71M
PB Ratio:
2.66
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 84.73
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -5.37
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 0.08
9-Day RSI 3.42
14-Day RSI 14
6-1 Month Momentum % -36.45
12-1 Month Momentum % -53.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.14
Quick Ratio 19.14
Cash Ratio 16.57

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.6

Profitability Rank

Name Current Vs Industry Vs History
ROE % -34.34
ROA % -32
ROIC % -488.62
ROC (Joel Greenblatt) % -1725.85
ROCE % -44.49
Years of Profitability over Past 10-Year 1

Financials

ATHJF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ATHJF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.007
Beta 2.04
Volatility % 137.56
14-Day RSI 14
14-Day ATR ($) 0.000019
20-Day SMA ($) 0.06355
12-1 Month Momentum % -53.98
52-Week Range ($) 0.0605 - 0.2973
Shares Outstanding (Mil) 668.79

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Antisense Therapeutics Ltd Filings

Document Form Filing Date
No Filing Data

Antisense Therapeutics Ltd Analysis

Share your research

Headlines

See More
No news.